| 000 | 01143 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514163827.0 | ||
| 264 | 0 | _c20040614 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a1699-3993 | ||
| 024 | 7 |
_a10.1358/dot.2003.39.10.799470 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMills, Roger M | |
| 245 | 0 | 0 |
_aNesiritide in perspective: evolving approaches to the management of acute decompensated heart failure. _h[electronic resource] |
| 260 |
_bDrugs of today (Barcelona, Spain : 1998) _cOct 2003 |
||
| 300 |
_a767-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNatriuretic Agents _xpharmacology |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xpharmacology |
| 650 | 0 | 4 | _aProduct Surveillance, Postmarketing |
| 700 | 1 | _aHobbs, Robert E | |
| 773 | 0 |
_tDrugs of today (Barcelona, Spain : 1998) _gvol. 39 _gno. 10 _gp. 767-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1358/dot.2003.39.10.799470 _zAvailable from publisher's website |
| 999 |
_c14401734 _d14401734 |
||